Clinical Trial: Safety of Imovax Polio in Chinese Infants and Children
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Clinical Safety Evaluation Study of the Sanofi Pasteur's Inactivated Poliomyelitis Vaccine (IMOVAX Polio™) Administered as a Single Boos
Brief Summary: To describe the tolerance in terms of occurrence of serious adverse reactions and severe adverse reactions (injection site and systemic) within eight days after one dose of IMOVAX Polio™ administered in children and infants.
Detailed Summary:
Sponsor: Sanofi Pasteur, a Sanofi Company
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Sanofi
Dates:
Date Received: November 24, 2005
Date Started: November 2005
Date Completion:
Last Updated: January 20, 2014
Last Verified: January 2014